Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Booster dose of Covishield offers best immune response: Lancet study

by AIP Online Bureau | Jan 26, 2023 | Facts, Health, Pandemic

According to the study, even though homologous and heterologous boosting with Covishield or Covaxin in Covishield or Covaxin primed individuals are immunogenic and safe, boosting with Covishield produced better binding and functional antibodies, irrespective of...

Gap between 2nd Covid shot and booster likely to be 9-12 months: Report

by AIP Online Bureau | Dec 26, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic, Policy

The nitty-gritty of the gaps for the vaccines currently being used in India’s inoculation programme Covishield and Covaxin is being worked out, and a final decision over this will be taken soon, they said. New Delhi:The gap between the second dose of COVID-19...

Booster dose ‘every 6 months for many years’ will be new norm: Expert

by AIP Online Bureau | Dec 25, 2021 | Facts, Health, Pandemic

“I think booster shots, just like your annual influenza shot (are) something we just need to accept, it’s (Covid-19) not going to be with us for many weeks and months, it’s going to be with us for many years,” Trent Twomey, National President...

Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose

by AIP Online Bureau | Dec 6, 2021 | Eco/Invest/Demography, Health, Indian News, Pandemic

In view of loss of life during the second wave of the COVID-19 pandemic, the committee noted that the measures taken by the health ministry to contain or prevent the spread of SARS-COV-2 proved to be squarely inadequate and suggested that the focus should be on...

No scientific evidence in country underlines need for COVID-19 booster dose: ICMR’s Dr Samiran Panda

by AIP Online Bureau | Nov 22, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic, Policy, Workplace/Employee Benefits

Dr Tamorish Kole, President of Asian Society for Emergency Medicine (ASEM), said, “When we are talking about the third dose, we must prioritise with the low level of immunity, immune-compromised such as cancer patients and patients who received an organ...

Recent Posts

  • CCI clears merger of InsuranceDekho and RenewBuy entities
  • Elon Musk’s $1 trillion Tesla pay plan wins shareholder approval
  • Gold ETFs attract record net inflows in India, add $850 million in Oct
  • SEBI flags over 1 lakh misleading investment messages under ‘Sebi versus Scam’ initiative
  • WEF says AI robotics nanotech to transform agriculture, cites case studies from India

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy